{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:44:54Z","timestamp":1759099494822,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ahj.2008.03.015","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T04:09:40Z","timestamp":1210824580000},"page":"234-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting"],"prefix":"10.1016","volume":"156","author":[{"given":"Terry R.","family":"Ketch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Sacrinty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Lingle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Applegate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Kutcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Sane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.03.015_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.107.185752","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction: executive summary","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.015_bib2","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in non\u2013ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide","volume":"105","author":"Sabatine","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.015_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1373\/clinchem.2004.046292","article-title":"Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome","volume":"51","author":"Apple","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.ahj.2008.03.015_bib4","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/archinte.162.16.1885","article-title":"A utilization management intervention to reduce unnecessary testing in the coronary care unit","volume":"162","author":"Wang","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.03.015_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2007.11.037","article-title":"Routine hematological clinical tests as prognostic markers in patients with acute coronary syndromes","author":"Turner","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.03.015_bib6","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.03.015_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0008-6363(03)00355-9","article-title":"Preprocedural serum levels of acute phase reactants and prognosis after percutaneous coronary intervention","volume":"60","author":"Rahel","year":"2003","journal-title":"Cardiovascular Res"},{"key":"10.1016\/j.ahj.2008.03.015_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0002-9149(96)90386-0","article-title":"Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non\u2013Q wave myocardial infarction (TIMI IIIB Trial)","volume":"78","author":"Becker","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.03.015_bib9","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1161\/01.CIR.96.12.4204","article-title":"Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease","volume":"96","author":"Toss","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.015_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04256.x","article-title":"Guidelines on fibrinogen assays","volume":"121","author":"Mackie","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ahj.2008.03.015_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0049-3848(88)90029-1","article-title":"Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers","volume":"52","author":"Rossi","year":"1988","journal-title":"Throm Res"},{"key":"10.1016\/j.ahj.2008.03.015_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristics curves: a non-parametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.ahj.2008.03.015_bib13","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1001\/archinte.165.21.2454","article-title":"When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk","volume":"165","author":"Greenland","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.03.015_bib14","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2008.03.015_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V64.4.797.797","article-title":"Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb\/IIIa complex when platelets are stimulated with thrombin","volume":"64","author":"Gralnick","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.ahj.2008.03.015_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ahj.2008.03.015_bib17","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1538-7836.2007.02677.x","article-title":"A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease","volume":"5","author":"Woodward","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2008.03.015_bib18","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1172\/JCI30134","article-title":"Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin aMb2 binding motif","volume":"117","author":"Flick","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2008.03.015_bib19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/eurheartj\/ehm031","article-title":"STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC\/ACC definition (the OPERA registry)","volume":"28","author":"Montalescot","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.03.015_bib20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/eurheartj\/ehm159","article-title":"STEMI and NSTEMI: the dangerous brothers","volume":"28","author":"Bode","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.03.015_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00001721-199804000-00006","article-title":"Measurement of plasma fibrinogen concentration by prothrombin-time\u2013derived method : applicability and limitations","volume":"9","author":"De Cristofaro","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ahj.2008.03.015_bib22","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1046\/j.1538-7836.2003.00467.x","article-title":"Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction","volume":"1","author":"Lowe","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2008.03.015_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cccn.2004.04.004","article-title":"Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes","volume":"346","author":"Wiviott","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ahj.2008.03.015_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jacc.2004.04.033","article-title":"B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy","volume":"44","author":"Mega","year":"2004","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:35:37Z","timestamp":1757568937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0002870308002214"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.03.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}